Muzinich & Co’s Medical Properties Trust MPT Stock Holding History

Muzinich & Co’s Portfolio MPT Stock Details MPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-82,500	Closed	-$678K	–	71
2023 Q1	$678K	Buy	+82,500	New	+$911K	0.49%	35

Other funds holding MPT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Muzinich & Co's MPT Position: Q2 2023 in Review

Muzinich & Co sold out of Medical Properties Trust (MPT) in Q2 2023, closing a stake of 82,500 shares — an estimated $678K sold.

Muzinich & Co first reported a position in MPT in Q1 2023 and held it in 1 quarter. The position peaked at $678K in Q1 2023. 596 funds tracked by Wall St. Rank hold MPT as of Q2 2023.

Muzinich & Co reported no remaining Medical Properties Trust position as of Q2 2023 after selling out during the quarter.
Muzinich & Co sold 82,500 Medical Properties Trust shares in Q2 2023, an estimated $678K.
Muzinich & Co first reported a position in Medical Properties Trust in Q1 2023 and held it in 1 quarter.
Muzinich & Co's Medical Properties Trust position peaked at $678K in Q1 2023.
596 funds tracked by Wall St. Rank held Medical Properties Trust as of Q2 2023.

Based on Muzinich & Co's 13F filing for Q2 2023, filed 11 Aug 2023.